• Principal investigators: Diana Puente Baliarda
• Code: 9F-0-00019-25
• Start year: 2025

Post-authorisation safety study to evaluate the utilisation and safety of atogepant in patients with migraine and significant cardiovascular and/or cerebrovascular disease in European countries

• Principal investigators: Talita Duarte Salles
• Code: 4RNC-0-00113-24
• Start year: 2025
• Funders: Pharmo Institute N.V.

Atlas de prescripción farmacéutica en Diabetes

• Principal investigators: Anna Moleras Serra, Anna Berenguera Ossó
• Code: 4RNC-0-00238-24
• Start year: 2025

Atlas para la monitorización de los cuidados en Diabetes

• Principal investigators: Anna Moleras Serra, Anna Berenguera Ossó
• Code: 4RNC-0-00270-24
• Start year: 2025

Regional Research Protocol to evaluate the effectiveness of dengue vaccines and the risk of Vaccine-Associated Enhanced Disease (VAED) in the Americas.

• Principal investigators: Felipe Villalobos Martínez
• Code: 4RNC-0-00340-25
• Start year: 2025
• Funders: American Health Organization/World Health Organization (PAHO/OPS)